Portola Pharmaceuticals Inc. (PTLA) Drops 10.24% on January 11

Equities Staff |

Portola Pharmaceuticals Inc. (PTLA) was one of the Russell 2000's biggest losers for Monday January 11 as the stock slid 10.24% to $38.08, a loss of $-4.345 per share. Starting at an opening price of $42.55 a share, the stock traded between $37.44 and $42.91 over the course of the trading day. Volume was 804,878 shares over 7,570 trades, against an average daily volume of 521,699 shares and a total float of 52.71 million.

The losses send Portola Pharmaceuticals Inc. down to a market cap of $2.01 billion. In the last year, Portola Pharmaceuticals Inc. has traded between $57.96 and $26.26, and its 50-day SMA is currently $49.32 and 200-day SMA is $45.53.

Portola Pharmaceuticals Inc is a biopharmaceutical company. It develops & commercializes novel therapeutics in the areas of thrombosis, other hematologic disorders & inflammation for patients who currently have limited or no approved treatment options.

Portola Pharmaceuticals Inc. is based out of South San Francisco, CA and has some 70 employees. Its CEO is William Lis.

For a complete fundamental analysis analysis of Portola Pharmaceuticals Inc., check out Equities.com’s Stock Valuation Analysis report for PTLA. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Lomiko Metals Inc.

Lomiko Metals Inc is an exploration stage company. It is engaged in the acquisition, exploration and development of resource properties. Its projects include Vines Lake project and Quatre - Milles…

Private Markets


D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…